TACE/ADAM-17: A Component of the Epidermal Growth Factor Receptor Axis and a Promising Therapeutic Target in Colorectal Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-1216
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Immunohistochemical Expression of the Promising Therapeutic Target (Human Epidermal Growth Factor Receptor 2/Neu) in Iraqi Patients With Medulloblastoma

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Insulin-Like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

Activating Stress-Activated Protein Kinase-Mediated Cell Death and Inhibiting Epidermal Growth Factor Receptor Signaling: A Promising Therapeutic Strategy for Prostate Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

EZH2 in Bladder Cancer, a Promising Therapeutic Target

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2015English

The Elabela-Apj Axis: A Promising Therapeutic Target for Heart Failure

Heart Failure Reviews
Cardiovascular MedicineCardiology
2020English

The PD1/PDL1 Axis, a Promising Therapeutic Target in Aggressive Breast Cancers

OncoImmunology
OncologyAllergyImmunology
2015English

Bag-1l: A Promising Therapeutic Target for Androgen Receptor-Dependent Prostate Cancer

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2019English

Overexpression of Epidermal Growth Factor Receptor as a Prognostic Factor in Colorectal Cancer on the Basis of the Allred Scoring System

OncoTargets and Therapy
OncologyPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy